Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
Chigusa Morizane(National Cancer Centre Japan), Takuji Okusaka, Junki Mizusawa, Hiroshi Katayama, Makoto Ueno(Kanagawa Prefectural Hospital Organization), Masafumi Ikeda(National Cancer Center Hospital East), Masato Ozaka(Cancer Institute (WIA)), Naohiro Okano(Kyorin University), Kazuya Sugimori(Yokohama City University Medical Center), Akira Fukutomi(Shizuoka Cancer Center), Hiroki Hara(Saitama Cancer Center), Nobumasa Mizuno(Aichi Cancer Center), Hiroaki Yanagimoto(Kansai Medical University), Keita Wada(Teikyo University), Kazutoshi Tobimatsu(Kobe University), Kei Yane(Teine Keijinkai Hospital), Shoji Nakamori(Osaka National Hospital), Hiroyuki Yamaguchi(Jichi Medical University), Akinori Asagi(Shikoku Cancer Center), Seigo Yukisawa(Tochigi Cancer Center), Yasushi Kojima(National Center for Global Health and Medicine), Ken Kawabe(Kyushu University), Yasuyuki Kawamoto(Hokkaido University Hospital), Rie Sugimoto(National Hospital Organization Kyushu Cancer Center), Tomohisa Iwai(Kitasato University Hospital), Kazuyoshi Nakamura(Chiba Cancer Center), Hiroyoshi Miyakawa(Sendai Kousei Hospital), Tatsuya Yamashita(Kanazawa University), A. Hosokawa(University of Toyama), Tatsuya Ioka(Osaka International Cancer Institute), Naoya Kato(Chiba University), Kazuhiko Shioji(Niigata Cancer Center Hospital), Kyoko Shimizu(Tokyo Women's Medical University), Toshio Nakagohri(Tokai University), Ken Kamata(Kindai University), Hiroshi Ishii(Chiba Cancer Center), Junji Furuse(Kyorin University)
Cited by 331
Abstract
Related Papers
No related papers found
Powered by citation graph analysis